Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
- DOI
- 10.1016/s0140-6736(25)01682-4
- Published
- 2025 Sep 27
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-25-01682-4,
title = {Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.},
author = {Zannad F and O'Connor CM and Butler J and McMullan CJ and Anstrom KJ and Barash I and Bonaca MP and Borentain M and Corda S and Gates D and Ezekowitz JA and Hernandez AF and Lam CSP and Lewis EF and Lindenfeld J and Mentz RJ and Ponikowski P and Reddy YNV and Rosano GMC and Saldarriaga C and Senni M and Teixeira PP and Udelson J and Urbinati A and Vlajnic V and Voors AA and Xing A and Patel MJ and Armstrong PW and VICTORIA and VICTOR Study Groups},
year = {2025},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(25)01682-4},
url = {https://doi.org/10.1016/s0140-6736(25)01682-4}
}RIS
TY - JOUR TI - Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. AU - Zannad F AU - O'Connor CM AU - Butler J AU - McMullan CJ AU - Anstrom KJ AU - Barash I AU - Bonaca MP AU - Borentain M AU - Corda S AU - Gates D AU - Ezekowitz JA AU - Hernandez AF AU - Lam CSP AU - Lewis EF AU - Lindenfeld J AU - Mentz RJ AU - Ponikowski P AU - Reddy YNV AU - Rosano GMC AU - Saldarriaga C AU - Senni M AU - Teixeira PP AU - Udelson J AU - Urbinati A AU - Vlajnic V AU - Voors AA AU - Xing A AU - Patel MJ AU - Armstrong PW AU - VICTORIA and VICTOR Study Groups PY - 2025 JO - Lancet (London, England) DO - 10.1016/s0140-6736(25)01682-4 UR - https://doi.org/10.1016/s0140-6736(25)01682-4 ER -
APA
F, Z., CM, O., J, B., CJ, M., KJ, A., I, B., MP, B., M, B., S, C., D, G., JA, E., AF, H., CSP, L., EF, L., J, L., RJ, M., P, P., YNV, R., GMC, R., C, S., M, S., PP, T., J, U., A, U., V, V., AA, V., A, X., MJ, P., PW, A., & Groups, V. A. V. S. (2025). Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)01682-4
Source records
- pubmed · retrieved 2026-09-25T11:55:36.731Z